Loading...
Home2020-01-16T14:12:51+01:00

GET OUR LATEST REPORTS DELIVERED TO YOUR INBOX

Utopiacap.com launched to the public in July 2019, initially with eight “Hindsight” reports, which looked at suspect tickers after their price declined.  

From August 2019 we started focusing on carefully timed short reports which seek to act as short calls as well as warn potential investors/traders of suspicious tickers. From November 19, 2019, our short reports started being 3rd party verified by  www.breakoutpoint.com

In total, we have covered and published thirteen short reports/calls (twelve profitable), ten of which have been tracked by Breakout Point (nine profitable). Giving us a 90% 3rd party verified success rate.

For more about us click HERE or read latest reports below.

.

Watchlist Report NVAX, Novavax, Inc., January 21, 2020

Welcome to our first Watchlist Report, in these reports we discuss potential shorts which have not yet met the necessary conditions to be actionable. THESE REPORTS ARE NOT SHORT REPORTS. In the case of NVAX, we would not consider it a short candidate unless its price per share surpasses the $10 mark. Intro: In our first watchlist report we have Novavax (NVAX), whose remarkable price increase and record volume during today’s [...]

January 21st, 2020|

Cemtrex, Inc. Nasdaq: CETX Short report, January 16, 2020

Intro: A quick look at CETX’s price action over the last twelve months will reveal a “bumpy” downward slope. We believe the present time is yet another “bump” in this ticker’s continued yet prolonged southward trajectory. In this short report we will be analysing some of the red flags investors and traders ought to be aware of, such as: securities class action lawsuits, worsening financials, dilution and a couple of institutional shareholders [...]

January 16th, 2020|

CounterPath Corp. Nasdaq: CPAH Short Report, January 13, 2020

Intro: Another week, another short report highlighting red flags to potential investors/traders. This time around we present to you CounterPath Corp. (CPAH). CPAH popped up in our radars last Friday due to its ludicrous 300% price increase relative to Thursday’s closing price, volume exceeding 42 million shares (seven times the number of outstanding shares) and RSI (14) breaching 94. The reason touted for the drastic increase in the company’s share price was [...]

January 13th, 2020|

Trillium Therapeutics Inc. Nasdaq: TRIL Short Report, January 10, 2020

Intro: Once again, we bring to your attention a ticker that has exhibited the usual behaviour that makes us warry. TRIL’s share price saw a near 100% increase yesterday with RSI (14) exceeding 85 and volume reaching record levels by a significant margin. We will thus be taking a look at some of the red flags the company rises in order to offer a more bearish perspective. Security Details (January [...]

January 10th, 2020|

Inpixon Nasdaq: INPX Short Report, January 6, 2020

Intro: INPX short report Another week, another report on a suspicious ticker. This time we present to you Inpixon (INPX). Its share price has increased by more than ten-fold over the last three weeks, volume at all-time record levels by a significant margin and daily RSI (14) exceeds 90. INPX also raises some eyebrows when a look is taken at its share issuance practices, its lenders and the underwriter of one its latest public offerings. [...]

January 6th, 2020|

FuelCell Energy, Inc. Nasdaq: FCEL Short Report, January 2, 2020

Intro: Like most of the tickers featured in our short reports FCEL has exhibited a combination of a drastic price increase (a near ten-fold price increase over the last 2 months), trading volume substantially above the 30-day daily average (151.5 million vs 25.7 million) and high RSI (92). One might argue that this is not a particularly strange occurrence in the world of small caps but upon further inspection we have found [...]

January 2nd, 2020|

Investor Warning: Oncolytics Biotech Inc. Nasdaq: ONCY, December 31,2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Current price: ~$5 Outstanding shares: 20,298,482 Market cap: ~$ 100 million Company information: Oncolytics Biotech Inc. was formed on April 1998 in Alberta Canada. Since its inception it has [...]

December 31st, 2019|

Isracann Biosciences Inc. Pink: ISCNF Short Report, December 27, 2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Intro: Isracann Biosciences Inc. has had quite the run over the last ten trading days with its share price increasing by nearly 100% from less than [...]

December 27th, 2019|

IVERIC Bio Inc. Nasdaq: ISEE Short Report, December 11, 2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Intro: IVERIC Bio, Inc. has had quite the run over the last six weeks with its share increasing from less than $1 to more than $5, [...]

December 11th, 2019|

Proteostasis Therapeutics, Inc. Nasdaq: PTI Short Report, December 6, 2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Intro: Like all other tickers featured in our short reports, PTI’s price action has exhibited unusual behaviour recently. Over the last three weeks its share price [...]

December 6th, 2019|

Investor Warning: Rivex Technology Corp. (Pink: RIVX), Nov 26, 2019

Share price: $7.01 Outstanding shares: 6,180,000 Market Cap: 43,321,800 Like all other tickers we discuss, RIVX has recently displayed highly dubious behaviour with its share price increasing from $2.80 to more than $6.00 and its volume reaching tens of thousands over the last few days despite it being virtually non-existent during the previous month. RIVX claims to be in the “business of development and sale of mobile games for Apple and Android platform”. We say [...]

November 26th, 2019|

NexTech AR Solutions Corp. OTCQB: NEXCF Short Report, Nov 19, 2019

If you find this short report useful please consider signing up for our premium service. You will receive our short reports directly to your email before they are published on our website and will also gain access to a due diligence, research and trading chatroom. Intro: Like all other tickers featured in our short reports, NEXCF has exhibited highly suspect behaviour recently. Over the last three weeks its share price has [...]

November 19th, 2019|

GRN Holdings Corp. (Pink: GRNF) formerly (Pink: DCGD), One of the greatest pump and dumps of our time?

GET OUR LATEST REPORTS DELIVERED TO YOUR INBOX As some of you might know we have been keeping a close eye on GRN Holdings Corp. (Pink: GRNF) (formerly Discovery Gold Corp. DCGD) over the last couple of months and in the process have written three short posts which shed some light on this very dubious stock. Despite the information we have unearthed (which in our opinion offers plenty of reasons to [...]

November 13th, 2019|

Qualibou Energy Inc. Pink: QALB Short Report

This report was first published and distributed to our premium service members on October 30th 2019. For more details please click here. Intro: QALB’s recent and sudden price and volume spikes have drawn our attention. Over the last seven trading days its price has increased by 3,000% and its volume has gone from virtually non-existent to exceeding the 300,000 mark. This is baffling, especially if one bares in mind that no [...]

November 7th, 2019|

Discovery Gold Corp. (Pink: DCGD) Part 3, latest 10Q show DCGD remains an empty shell, CEO lied about education and has been named as a defendant on four separate court cases over the last five years

Discovery Gold Corp. (DCGD) has been quite the roller-coaster over the last couple of months as shown by its share price volatility. This comes as no surprise given the strong contrasts that exists between the statements made by the new owners/management and recent filings as well as the findings of Utopia Capital and other researchers. According to GRN Holdings (the new owners/management) they are a multi million-dollar cannabis business that intends to expand its [...]

October 9th, 2019|